Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity

URN:NBN:SI:doc-BPYUPHHB2012Debeljak, NatašaJuvan, PeterSerša, GregorTrošt, Ninadocuments/doc/B/URN_NBN_SI_doc-BPYUPHHB_001.htmdocuments/doc/B/URN_NBN_SI_doc-BPYUPHHB_001.pdfdocuments/doc/B/URN_NBN_SI_doc-BPYUPHHB_001.txt346articlestr. 213-2251318-209930028761URN:NBN:SI:doc-BPYUPHHBengAssociation of Radiology and OncologyRadiology and oncology (Ljubljana)BYbreastbreast cancerBreast neoplasmsCell divisionCell survivalCisplatincitotoksičnostcytotoxicitydojkeDrug therapyeritropoetinerythropoietinErythropoietin, recombinantGene expressionGenes, bcl-2Genes, p53rak (medicina)ToxicityTumor cells, culturedContrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity